Fludrocortisone

DEA Class; Rx

Common Brand Names; Florinef, Florinef Acetate

  • Corticosteroids

Potent oral synthetic fluorinated mineralocorticoid; no appreciable glucocorticoid activity
Actions are similar to those of aldosterone
Used for conditions of adrenocortical insufficiency and orthostatic hypotension

Indicated for Primary and secondary adrenocortical insufficiency in Addison disease

For the treatment of primary adrenocortical insufficiency (e.g., Addison’s Disease, congenital adrenal hyperplasia or CAH), secondary adrenocortical insufficiency, or salt-losing adrenogenital syndrome.
For the treatment of neurogenic orthostatic hypotension, including due to diabetic cardiovascular autonomic neuropathy or Parkinson’s disease dysautonomia.

Systemic fungal infection

Documented hypersensitivity

Receipt of live or attenuated live vaccine; Advisory Committee on Immunization Practices (ACIP) and American Academy of Family Physicians (AAFP) state that administration of live virus vaccines usually is not contraindicated in patients receiving corticosteroid therapy as short-term (<2 weeks) treatment, in low-to-moderate dosages, as long-term alternate-day treatment with short-acting preparations, or in maintenance of physiologic dosages (replacement therapy)

  • Acne
  • Adrenal suppression
  • Change in spermatogenesis
  • Delayed wound healing
  • Diabetes mellitus
  • GI perforation
  • Glucose intolerance
  • Hepatomegaly
  • Hypokalemic alkalosis
  • Increased transaminases
  • Insomnia
  • Menstrual irregularity
  • Myopathy
  • Neuritis
  • Osteoporosis
  • Peptic ulcer
  • Perianal pruritus
  • Pituitary adrenal axis suppression
  • Pseudotumor cerebri (on withdrawal)
  • Psychosis
  • Seizure
  • Ulcerative esophagitis
  • Urticaria
  • Vertigo
  • Weight gain

Use with caution in diabetes mellitus, hypertension, hypothyroidism, electrolyte abnormalities, sodium and water retention, infections, immunizations, ocular herpes simplex, myasthenia gravis, peptic ulcer disease, psychosis, renal insufficiency

Thromboembolic disorders and myopathy may occur

Delayed wound healing is possible

Patients receiving corticosteroids should avoid chickenpox or measles-infected persons if unvaccinated

Latent tuberculosis may be reactivated (patients with positive tuberculin test should be monitored)

Some suggestion (not fully substantiated) of slightly increased cleft palate risk if corticosteroids are used in pregnancy

Prolonged corticosteroid use may result in elevated intraocular pressure, glaucoma, or cataracts and has been associated with development of Kaposi sarcoma

Myopathy has been reported

Pregnancy category: C

Lactation: Unknown whether drug is excreted in milk; use with caution

Adults

Maintenance therapy usual max: 0.2 mg/day PO.

Geriatric

Maintenance therapy usual max: 0.2 mg/day PO.

Adolescents

Safety and efficacy have not been established, but doses of up to 0.3 mg/day PO have been used.

Children

Safety and efficacy have not been established, but doses of up to 0.3 mg/day PO have been used.

Infants

Safety and efficacy have not been established, but doses of up to 0.3 mg/day PO have been used.

Neonates

Safety and efficacy have not been established, but doses of up to 0.3 mg/day PO have been used.

Fludrocortisone acetate

tablet

  • 0.1mg

About the Author

You may also like these

0